Reporter at Reuters covering healthcare, consumer and retail M&A olivia.oran@thomsonreuters.com

Jana Partners lines up five executives to serve on PetSmart board: filing

reuters.com — Jana, which has a 9.8 percent stake in PetSmart, may nominate former Caremark executive Edwin "Mac" Crawford; former RadioShack Corp Chief Executive Officer Julian Day; former Harris Teeter CEO Thomas Dickson; One Kings Lane co-founder Susan Feldman; and former Wal-Mart Stores Inc executive Lawrence Jackson.

UPDATE 1-Jana Partners lines up 5 executives to serve on PetSmart board -filing

reuters.com — By Nadia Damouni and Olivia Oran Nov 20 (Reuters) - Jana Partners LLC has lined up five executives who are willing to serve as directors on PetSmart Inc's board if the activist hedge fund is not satisfied with the outcome of the pet food retailer's strategic review, the fund said in a filing on Thursday.

Exclusive: KKR, CD&R prepare joint bid for PetSmart: sources

reuters.com — Credit: Reuters/David McNew Jasmine Dugas blow dries a dog after it was bathed at a PetSmart PetsHotel and Doggie Day Camp in Los Angeles, California, May 14, 2012. KKR and CD&R are planning to submit a joint bid for PetSmart next month, the people said.

Losing Allergan deals blow to Valeant reputation

reuters.com — Credit: Reuters/Christinne Muschi The head offices of Valeant Pharmaceuticals International Inc. are seen in Laval, Quebec May 20, 2014. Losing Allergan to Actavis PLC also hurts Valeant's deal-making reputation, said a source close to the company not authorized to speak publicly. Allergan announced a $66 billion deal with Actavis on Monday that trumped Valeant's offer.

Allergan near buyout of up to $65 billion to escape Valeant, Ackman: source

mobile.reuters.com — Allergan near buyout of up to $65 billion to escape Valeant, Ackman: source By Olivia Oran and Svea Herbst-Bayliss (Reuters) - Allergan Inc is close to a buyout deal worth up to $65.5 billion by Actavis Plc, one that could end months of pursuit by Canada's Valeant Pharmaceuticals and William Ackman's hedge fund, Pershing Square Capital Management, according to a person familiar with the matter.

Source: Allergan near buyout of up to $65 billion to escape Valeant, Ackman

stltoday.com — Allergan Inc. is close to a buyout deal worth up to $65.5 billion by Actavis PLC, one that could end months of pursuit by Canada's Valeant Pharmaceuticals and William Ackman's hedge fund, Pershing Square Capital Management, according to a person familiar with the matter.

Cosmetics company Too Faced up for sale: sources

reuters.com — The Irvine, California-based cosmetics company, which is partially owned by private equity firm Weston Presidio, is working with investment bank Piper Jaffray on the sale process, which is expected to kick off early next year, the people said. The sources declined to be named because the matter is private.

Salix inventory issues sink deal with Allergan

in.reuters.com — (Reuters) - Salix Pharmaceuticals Ltd slashed its full-year forecast on Thursday and said inventory for its key drugs piled up, an issue that people familiar with the matter said dissuaded Allergan Inc from acquiring the drugmaker.

UPDATE 2-Salix inventory issues sink deal with Allergan

mobile.reuters.com — UPDATE 2-Salix inventory issues sink deal with Allergan (Adds details of failed talks with Allergan) By Olivia Oran and Nadia Damouni Nov 6 (Reuters) - Salix Pharmaceuticals Ltd slashed its full-year forecast on Thursday and said inventory for its key drugs piled up, an issue that people familiar with the matter said dissuaded Allergan Inc Inc from acquiring the drugmaker.

MOVES-Deutsche Bank IPO adviser known for tweeting goes to Morgan Stanley-sources

reuters.com — Based in San Francisco, Tobiason works on tech software and Internet IPOs in Silicon Valley. His new role at Morgan Stanley is not yet clear. Tobiason, a managing director, had been at Deutsche Bank since 2006 after joining from Bank of America. Representatives for Deutsche Bank and Morgan Stanley declined to comment.
More Articles →
Nov 20, 2014

Jana Partners lines up retail execs for PetSmart board. List includes former Wal-Mart, RadioShack execs reut.rs/1ufHyyQ @nadiaspeaks

Nov 20, 2014

Jana confirms Reuters scoop from yesterday that it is preparing to nominate board members for PetSmart $PETM

Nov 17, 2014

Actavis-Allergan deal comes in at $219/share. Reuters said last night deal would likely come in at high end of $215-$220/share range

Nov 16, 2014

Allergan-Actavis deal likely to come between $215 and $220 per share, according to our sources reut.rs/1xMsbn6

Nov 11, 2014

Cosmetics company Too Faced, known for fake lashes and bronzers, looking for new owner: reuters.com/article/2014/1…

Nov 10, 2014

Back in NYC after a week full of meetings in SF. What'd I miss?

Learn how to connect with Olivia on social media by joining Muck Rack Pro



Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.


Share This Profile